541 related articles for article (PubMed ID: 24534415)
21. Lithium's antisuicidal efficacy: elucidation of neurobiological targets using endophenotype strategies.
Kovacsics CE; Gottesman II; Gould TD
Annu Rev Pharmacol Toxicol; 2009; 49():175-98. PubMed ID: 18834309
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.
Malhi GS; Outhred T
CNS Drugs; 2016 Oct; 30(10):931-49. PubMed ID: 27638546
[TBL] [Abstract][Full Text] [Related]
23. Preliminary investigation of lithium for mood disorder symptoms in children and adolescents with autism spectrum disorder.
Siegel M; Beresford CA; Bunker M; Verdi M; Vishnevetsky D; Karlsson C; Teer O; Stedman A; Smith KA
J Child Adolesc Psychopharmacol; 2014 Sep; 24(7):399-402. PubMed ID: 25093602
[TBL] [Abstract][Full Text] [Related]
24. [Mood stabilizers--past, present and future].
Sümegi A
Neuropsychopharmacol Hung; 2008 Mar; 10(1):31-42. PubMed ID: 18771018
[TBL] [Abstract][Full Text] [Related]
25. Lithium Pharmacology and a Potential Role of Lithium on Methamphetamine Abuse and Dependence.
Kitanaka N; Hall FS; Uhl GR; Kitanaka J
Curr Drug Res Rev; 2019; 11(2):85-91. PubMed ID: 31875781
[TBL] [Abstract][Full Text] [Related]
26. Understanding suicide: Focusing on its mechanisms through a lithium lens.
Malhi GS; Das P; Outhred T; Irwin L; Morris G; Hamilton A; Lynch K; Mannie Z
J Affect Disord; 2018 Dec; 241():338-347. PubMed ID: 30142593
[TBL] [Abstract][Full Text] [Related]
27. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
28. Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: Potential involvement of epigenetics.
Pisanu C; Papadima EM; Del Zompo M; Squassina A
Neurosci Lett; 2018 Mar; 669():24-31. PubMed ID: 27343410
[TBL] [Abstract][Full Text] [Related]
29. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
30. Lithium treatment - the state of the art for 2020.
Rybakowski J
Psychiatr Pol; 2020 Dec; 54(6):1047-1066. PubMed ID: 33740796
[TBL] [Abstract][Full Text] [Related]
31. Search for a common mechanism of mood stabilizers.
Harwood AJ; Agam G
Biochem Pharmacol; 2003 Jul; 66(2):179-89. PubMed ID: 12826261
[TBL] [Abstract][Full Text] [Related]
32. What is the Role of Lithium in Epilepsy?
Bojja SL; Singh N; Kolathur KK; Rao CM
Curr Neuropharmacol; 2022; 20(10):1850-1864. PubMed ID: 35410603
[TBL] [Abstract][Full Text] [Related]
33. Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs.
Le-Niculescu H; Roseberry K; Gill SS; Levey DF; Phalen PL; Mullen J; Williams A; Bhairo S; Voegtline T; Davis H; Shekhar A; Kurian SM; Niculescu AB
Mol Psychiatry; 2021 Jul; 26(7):2776-2804. PubMed ID: 33828235
[TBL] [Abstract][Full Text] [Related]
34. Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades.
Wada A
J Pharmacol Sci; 2009 May; 110(1):14-28. PubMed ID: 19423950
[TBL] [Abstract][Full Text] [Related]
35. Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection.
Li X; Bijur GN; Jope RS
Bipolar Disord; 2002 Apr; 4(2):137-44. PubMed ID: 12071511
[TBL] [Abstract][Full Text] [Related]
36. Genomics of Lithium Action and Response.
Pickard BS
Neurotherapeutics; 2017 Jul; 14(3):582-587. PubMed ID: 28639153
[TBL] [Abstract][Full Text] [Related]
37. Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects.
Quiroz JA; Machado-Vieira R; Zarate CA; Manji HK
Neuropsychobiology; 2010; 62(1):50-60. PubMed ID: 20453535
[TBL] [Abstract][Full Text] [Related]
38. Exploring lithium's transcriptional mechanisms of action in bipolar disorder: a multi-step study.
Akkouh IA; Skrede S; Holmgren A; Ersland KM; Hansson L; Bahrami S; Andreassen OA; Steen VM; Djurovic S; Hughes T
Neuropsychopharmacology; 2020 May; 45(6):947-955. PubMed ID: 31652432
[TBL] [Abstract][Full Text] [Related]
39. Lithium for maintenance treatment of mood disorders.
Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
[TBL] [Abstract][Full Text] [Related]
40. Twenty years of Lithium pharmacogenetics: A systematic review.
Pagani R; Gasparini A; Ielmini M; Caselli I; Poloni N; Ferrari M; Marino F; Callegari C
Psychiatry Res; 2019 Aug; 278():42-50. PubMed ID: 31146140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
